Abstract Details
|
Brian G. Weinshenker, MD, FAAN
(University of Virginia Health System)
PRESENTER |
Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. |
| Filippo Savoldi, MD | No disclosure on file |
| Zahra Nasr, MD (Isfahan Multiple Sclerosis Society) | Dr. Nasr has nothing to disclose. |
| Wei Hu, MD, PhD (University of Florida) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Jayawant N. Mandrekar, PhD | Dr. Mandrekar has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file |